[Improvement in anti-hemophilic preparations and its problems. 5. Stability and oral administration of factor VIII and IX concentrates].
Oguma
Y
Y
Shimizu
K
K
Sakuragawa
N
N
D000284:Administration, Oral; D000327:Adsorption; D000818:Animals; D002214:Capsules; D004285:Dogs; D004355:Drug Stability; D005164:Factor IX / Q000008:administration & dosage*; D005169:Factor VIII / Q000008:administration & dosage*; D006467:Hemophilia A / Q000628:therapy; D008081:Liposomes; D011092:Polyethylene Glycols
D002214:Capsules; D008081:Liposomes; D011092:Polyethylene Glycols; D005169:Factor VIII; D005164:Factor IX